search
Back to results

Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

Primary Purpose

Agitation, Alzheimer's Type Dementia

Status
Recruiting
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Masupirdine 50 mg
Masupirdine 100 mg
Placebo
Sponsored by
Suven Life Sciences Limited
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Agitation focused on measuring Masupirdine, SUVN-502, Phase 3, Agitation

Eligibility Criteria

50 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Has a diagnosis of dementia of the Alzheimer's type according to the National Institute on Aging-Alzheimer's Association (NIA-AA) criteria.
  • Has confirmed agitation using the IPA Consensus Provisional Definition of Agitation in Cognitive Disorders.
  • Has a score between 8 and 24 (both inclusive) on Mini-Mental State Examination (MMSE).

Exclusion Criteria:

  • Participants with dementia predominantly of the non-Alzheimer's type (e.g., vascular dementia, parkinson's disease, lewy body disease, frontotemporal dementia)
  • Has symptoms of agitation that are not secondary to Alzheimer's disease (eg, pain, other psychiatric disorder, or delirium due to a metabolic disorder, systemic infection, or substance-induced).
  • Participant (or caregiver) is deemed otherwise ineligible for participation in this study in the investigator's judgement.

Sites / Locations

  • Advanced Research Center, Inc.Recruiting
  • ATP Clinical Research, Inc.Recruiting
  • Neuro Pain Medical CenterRecruiting
  • Neurology Center of North Orange CountyRecruiting
  • Mary S Easton Center for Alzheimer's Research and Care UCLARecruiting
  • Ki Health Partners, LLCRecruiting
  • Central Miami Medical InstituteRecruiting
  • Allied Biomedical Research InstituteRecruiting
  • CCM Clinical Research GroupRecruiting
  • Miami Jewish HealthRecruiting
  • Novel Clinical Research Center, LLC.Recruiting
  • Brainstorm ResearchRecruiting
  • Combined Research Orlando Phase I-IVRecruiting
  • Quantum Laboratories IncRecruiting
  • University of Kentucky Sanders-Brown Center on AgingRecruiting
  • Dent Neurologic InstituteRecruiting
  • North Suffolk NeurologyRecruiting
  • Mid Hudson Medical Research, PLLCRecruiting
  • Richmond Behavioral AssociatesRecruiting
  • Neuroscience Research Center, LLCRecruiting
  • Ralph H. Johnson VA Health Care SystemRecruiting
  • Palmetto Clinical ResearchRecruiting
  • Baylor College of MedicineRecruiting
  • Clinical Trial NetworkRecruiting
  • Clinical Hospital Center RijekaRecruiting
  • Polyclinic NeuronRecruiting
  • University Hospital Center ZagrebRecruiting
  • Klinika za psihijatriju Sveti IvanRecruiting
  • Klinika za psihijatriju VrapceRecruiting
  • EMC Instytut Medyczny S.A.Recruiting
  • Clinical Best Solutions - LublinRecruiting
  • ETG Lublin - PPDSRecruiting
  • NZOZ IGNIS dr med. Alicja LobinskaRecruiting
  • Osrodek Badan Klinicznych AppletreeclinicsRecruiting
  • Medycyna Milorzab sp. z o.o.Recruiting
  • Krakowska Akademia Neurologii Sp. z o.o.Recruiting
  • FutureMeds Warszawa CentrumRecruiting
  • Centrum Medyczne Silmedic Sp z o oRecruiting
  • Novo-Med Zielinski i wsp. Sp.J.Recruiting
  • Neuro-Medic Janusz ZbrojkiewiczRecruiting
  • Kiepury ClinicRecruiting
  • Clinical Hospital Center Dragisa Misovic DedinjeRecruiting
  • University Clinical Center of Serbia, Clinic for neurologyRecruiting
  • Special Hospital for Psychiatric DiseasesRecruiting
  • University Clinical Center Nis, Clinic for neurologyRecruiting
  • Clinical Centre of Vojvodina, Clinic of NeurologyRecruiting
  • Special Hospital for Psychiatric Diseases ''Dr Slavoljub Bakalovic''Recruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Placebo Comparator

Arm Label

Low Dose Masupirdine Arm

High Dose Masupirdine Arm

Placebo

Arm Description

Tablet

Tablet

Tablet

Outcomes

Primary Outcome Measures

Cohen-Mansfield Agitation Inventory (CMAI)
Change in CMAI items score aligning to the International Psychogeriatric Association (IPA) agitation criteria domains (physical aggression, excessive motor activity, and verbal aggression). CMAI is a validated 29-item questionnaire to assess agitation. Each item is rated on a 7-point scale ranging from 1 "Never" to 7 "Several times per hour". Higher scores indicate worsening agitation.

Secondary Outcome Measures

Modified Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (mADCS-CGI-C)
Change in mADCS-CGI-C. The mADCS-CGI-C is a modification of the ADCS-CGI-C instrument that focuses specifically on agitation. It is a 7-point Likert scale that ranges from marked improvement scored as 1 to marked worsening scored as 7. The range is from 1 to 7. Higher scores indicate worsening agitation.

Full Information

First Posted
May 25, 2022
Last Updated
August 14, 2023
Sponsor
Suven Life Sciences Limited
search

1. Study Identification

Unique Protocol Identification Number
NCT05397639
Brief Title
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Official Title
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Masupirdine (SUVN-502) for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 1, 2022 (Actual)
Primary Completion Date
January 2025 (Anticipated)
Study Completion Date
January 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Suven Life Sciences Limited

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will be conducted to evaluate the efficacy, safety, tolerability, and pharmacokinetics of masupirdine compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's type.
Detailed Description
This is a multicenter, randomized, double-blind, placebo-controlled study, consisting of 12 weeks of treatment. Approximately 375 participants will be enrolled at approximately 50 centers worldwide. Study medication will be administered orally once-daily from Day 1 through Day 85. Screening will occur within approximately 4 weeks prior to randomization. Following screening procedures for assessment of inclusion and exclusion criteria, eligible participants will be randomized into the study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Agitation, Alzheimer's Type Dementia
Keywords
Masupirdine, SUVN-502, Phase 3, Agitation

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Double-Blind
Allocation
Randomized
Enrollment
375 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Low Dose Masupirdine Arm
Arm Type
Experimental
Arm Description
Tablet
Arm Title
High Dose Masupirdine Arm
Arm Type
Experimental
Arm Description
Tablet
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Tablet
Intervention Type
Drug
Intervention Name(s)
Masupirdine 50 mg
Other Intervention Name(s)
SUVN-502
Intervention Description
Tablet, Once Daily
Intervention Type
Drug
Intervention Name(s)
Masupirdine 100 mg
Other Intervention Name(s)
SUVN-502
Intervention Description
Tablet, Once Daily
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Matching Placebo Tablet, Once Daily
Primary Outcome Measure Information:
Title
Cohen-Mansfield Agitation Inventory (CMAI)
Description
Change in CMAI items score aligning to the International Psychogeriatric Association (IPA) agitation criteria domains (physical aggression, excessive motor activity, and verbal aggression). CMAI is a validated 29-item questionnaire to assess agitation. Each item is rated on a 7-point scale ranging from 1 "Never" to 7 "Several times per hour". Higher scores indicate worsening agitation.
Time Frame
From Baseline to Week 12 visit
Secondary Outcome Measure Information:
Title
Modified Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (mADCS-CGI-C)
Description
Change in mADCS-CGI-C. The mADCS-CGI-C is a modification of the ADCS-CGI-C instrument that focuses specifically on agitation. It is a 7-point Likert scale that ranges from marked improvement scored as 1 to marked worsening scored as 7. The range is from 1 to 7. Higher scores indicate worsening agitation.
Time Frame
From Baseline to Week 12 visit

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Has a diagnosis of dementia of the Alzheimer's type according to the National Institute on Aging-Alzheimer's Association (NIA-AA) criteria. Has confirmed agitation using the IPA Consensus Provisional Definition of Agitation in Cognitive Disorders. Has a score between 8 and 24 (both inclusive) on Mini-Mental State Examination (MMSE). Exclusion Criteria: Participants with dementia predominantly of the non-Alzheimer's type (e.g., vascular dementia, parkinson's disease, lewy body disease, frontotemporal dementia) Has symptoms of agitation that are not secondary to Alzheimer's disease (eg, pain, other psychiatric disorder, or delirium due to a metabolic disorder, systemic infection, or substance-induced). Participant (or caregiver) is deemed otherwise ineligible for participation in this study in the investigator's judgement.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Study Contact
Phone
+9140 2319 3956
Email
agitation@suven.com
Facility Information:
Facility Name
Advanced Research Center, Inc.
City
Anaheim
State/Province
California
ZIP/Postal Code
92805-5854
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Steven Macina
Phone
714-493-7258
Email
dr.macina@arctrials.com
First Name & Middle Initial & Last Name & Degree
Steven Macina, DO
Facility Name
ATP Clinical Research, Inc.
City
Costa Mesa
State/Province
California
ZIP/Postal Code
92626-4607
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gustavo Alva
Phone
714-277-4472
Email
galva@atpcr.com
First Name & Middle Initial & Last Name & Degree
Gustavo Alva
First Name & Middle Initial & Last Name & Degree
Alejandro Alva
First Name & Middle Initial & Last Name & Degree
Vanessa Flores
First Name & Middle Initial & Last Name & Degree
Bobby Shih
Facility Name
Neuro Pain Medical Center
City
Fresno
State/Province
California
ZIP/Postal Code
93710-5473
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Perminder Bhatia, MD
Phone
559-437-9700
Email
bhatia@neuropain.com
Facility Name
Neurology Center of North Orange County
City
Fullerton
State/Province
California
ZIP/Postal Code
92835-1040
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kiran Bath, MD
Phone
714-879-7202
Email
drkbath@gmail.com
Facility Name
Mary S Easton Center for Alzheimer's Research and Care UCLA
City
Los Angeles
State/Province
California
ZIP/Postal Code
90095
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pauline Wu
Phone
310-794-6191
Email
pwu@mednet.ucla.edu
First Name & Middle Initial & Last Name & Degree
Pauline Wu, DO
Facility Name
Ki Health Partners, LLC
City
Stamford
State/Province
Connecticut
ZIP/Postal Code
06905
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Peter McAllister
Phone
203-914-1900
Email
peter@neinh.com
First Name & Middle Initial & Last Name & Degree
Peter McAllister, MD
First Name & Middle Initial & Last Name & Degree
Kathleen Mullin, MD
Facility Name
Central Miami Medical Institute
City
Miami
State/Province
Florida
ZIP/Postal Code
33122-1335
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Leonardo Alonso, MD
Phone
305-547-2011
Email
leonardo.alonsomd@gmail.com
First Name & Middle Initial & Last Name & Degree
Leonardo Alonso, MD
First Name & Middle Initial & Last Name & Degree
Magaly Alonso, MD
First Name & Middle Initial & Last Name & Degree
Melissa Ocana
Facility Name
Allied Biomedical Research Institute
City
Miami
State/Province
Florida
ZIP/Postal Code
33125-2607
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michael Pfeffer, MD
Phone
305-643-8400
Email
mpfeffer@abriusa.net
First Name & Middle Initial & Last Name & Degree
Michael Pfeffer, MD
Facility Name
CCM Clinical Research Group
City
Miami
State/Province
Florida
ZIP/Postal Code
33133
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Francisco Ricart, MD
Phone
208-346-8900
Email
ricart@ccmclinicalresearch.com
Facility Name
Miami Jewish Health
City
Miami
State/Province
Florida
ZIP/Postal Code
33137
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marc Agronin
Phone
305-751-8626
Email
magronin@miamijewishhealth.org
First Name & Middle Initial & Last Name & Degree
Marc Agronin, MD
Facility Name
Novel Clinical Research Center, LLC.
City
Miami
State/Province
Florida
ZIP/Postal Code
33143
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Heber Varela
Phone
786-773-2737
Email
hvarela@novelclinicalresearch.com
First Name & Middle Initial & Last Name & Degree
Heber Varela
Facility Name
Brainstorm Research
City
Miami
State/Province
Florida
ZIP/Postal Code
33176
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Brad Herskowitz
Phone
305-596-0657
Email
bherskowitz@brainstormresearch.net
First Name & Middle Initial & Last Name & Degree
Brad Herskowitz, MD
Facility Name
Combined Research Orlando Phase I-IV
City
Orlando
State/Province
Florida
ZIP/Postal Code
32807
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eric Carbonell
Phone
407-440-4493
Email
dr.carbonell@clinicaltrialsorlando.com
First Name & Middle Initial & Last Name & Degree
Eric Carbonell, MD
Facility Name
Quantum Laboratories Inc
City
Pompano Beach
State/Province
Florida
ZIP/Postal Code
33064
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jose De La Gandara
Phone
954-933-2324
Email
jedelagandara@quantum-lab.com
First Name & Middle Initial & Last Name & Degree
Jose De La Gandara, MD
Facility Name
University of Kentucky Sanders-Brown Center on Aging
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40536
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gregory Jicha
Phone
859-323-5550
Email
gregory.jicha@uky.edu
First Name & Middle Initial & Last Name & Degree
Gregory Jicha, MD
Facility Name
Dent Neurologic Institute
City
Amherst
State/Province
New York
ZIP/Postal Code
14226
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bela Ajtai
Phone
716-250-2038
Email
bajtai@dentinstitute.com
First Name & Middle Initial & Last Name & Degree
Bela Ajtai, MD
Facility Name
North Suffolk Neurology
City
Commack
State/Province
New York
ZIP/Postal Code
11725-2808
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Warren Spinner
Phone
631-364-9119
Ext
266
Email
wspinner@nsneuro.net
First Name & Middle Initial & Last Name & Degree
Warren Spinner, MD
Facility Name
Mid Hudson Medical Research, PLLC
City
New Windsor
State/Province
New York
ZIP/Postal Code
12553
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sashi Makam
Phone
845-674-9398
Email
smakam@mhmresearch.com
First Name & Middle Initial & Last Name & Degree
Sashi Makam, MD
Facility Name
Richmond Behavioral Associates
City
Staten Island
State/Province
New York
ZIP/Postal Code
10312-6501
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mark DiBuono, MD
Phone
718-317-5522
Email
dibuono@rbany.com
First Name & Middle Initial & Last Name & Degree
Mark DiBuono, MD
First Name & Middle Initial & Last Name & Degree
Adam Smith
First Name & Middle Initial & Last Name & Degree
Priya Selvarajah
First Name & Middle Initial & Last Name & Degree
Kimberly Colangelo
Facility Name
Neuroscience Research Center, LLC
City
Canton
State/Province
Ohio
ZIP/Postal Code
44718
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ryan Drake, DO
Phone
330-244-2542
Email
rsddo@neurocarecenter.com
Facility Name
Ralph H. Johnson VA Health Care System
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29401-1113
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jessica Broadway
Phone
843-412-4086
Email
Jessica.Broadway@va.gov
First Name & Middle Initial & Last Name & Degree
Jessica Broadway, MD
Facility Name
Palmetto Clinical Research
City
Summerville
State/Province
South Carolina
ZIP/Postal Code
29485
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Robert Carlile
Phone
843-851-7098
Email
rmcarlile@palmettoprimarycare.com
First Name & Middle Initial & Last Name & Degree
Robert Carlile
Facility Name
Baylor College of Medicine
City
Houston
State/Province
Texas
ZIP/Postal Code
77030-4202
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Melissa Yu
Phone
713-798-4734
Email
melissa.yu@bcm.edu
First Name & Middle Initial & Last Name & Degree
Melissa Yu, MD
Facility Name
Clinical Trial Network
City
Houston
State/Province
Texas
ZIP/Postal Code
77074
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Djamchid Lotfi
Phone
713-533-1480
Email
dlotfi@ctntexas.com
First Name & Middle Initial & Last Name & Degree
Djamchid Lotfi, MD
Facility Name
Clinical Hospital Center Rijeka
City
Rijeka
ZIP/Postal Code
51000
Country
Croatia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ika Roncevic-Grzeta
Phone
+38551658321
Email
ikaroncevic@gmail.com
First Name & Middle Initial & Last Name & Degree
Ika Roncevic-Grzeta
Facility Name
Polyclinic Neuron
City
Zagreb
ZIP/Postal Code
10000
Country
Croatia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Neven Henigsberg
Phone
+38514596866
Email
neven.henigsberg@zg.ht.hr
First Name & Middle Initial & Last Name & Degree
Neven Henigsberg
Facility Name
University Hospital Center Zagreb
City
Zagreb
ZIP/Postal Code
10000
Country
Croatia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fran Borovecki
Phone
+385912339876
Email
fran.borovecki@kbc-zagreb.hr
First Name & Middle Initial & Last Name & Degree
Fran Borovecki
Facility Name
Klinika za psihijatriju Sveti Ivan
City
Zagreb
ZIP/Postal Code
10090
Country
Croatia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Igor Filipčić
Phone
+3858888888888
Email
igor.filipcic@pbsvi.hr
First Name & Middle Initial & Last Name & Degree
Igor Filipčić
Facility Name
Klinika za psihijatriju Vrapce
City
Zagreb
ZIP/Postal Code
10090
Country
Croatia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ninoslav Mimica
Phone
+38513780678
Email
ninoslav.mimica@bolnica-vrapce.hr
First Name & Middle Initial & Last Name & Degree
Ninoslav Mimica
Facility Name
EMC Instytut Medyczny S.A.
City
Wrocław
State/Province
Dolnoslaskie
ZIP/Postal Code
50-220
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Monika Susz-Kolodynska
Phone
+48514954784
Email
jasuszka@poczta.onet.pl
Facility Name
Clinical Best Solutions - Lublin
City
Lublin
State/Province
Lubelskie
ZIP/Postal Code
20-078
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Aneta Tylec
Phone
+48788666693
Email
anetatylec@wp.pl
Facility Name
ETG Lublin - PPDS
City
Lublin
State/Province
Lubelskie
ZIP/Postal Code
20-412
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Magdalena Kalinowska-Krasnowska
Phone
+48722222288
Email
m.kalinowskakrasnowska@etg-network.com
Facility Name
NZOZ IGNIS dr med. Alicja Lobinska
City
Świdnik
State/Province
Lubelskie
ZIP/Postal Code
21-040
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alicja Lobinska
Phone
+48817512386
Email
alalob@tlen.pl
Facility Name
Osrodek Badan Klinicznych Appletreeclinics
City
Łódź
State/Province
Lódzkie
ZIP/Postal Code
90-349
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Agnieszka Karp-Majewska
Phone
+48605343098
Email
agnieszka.karp-majewska@appletree.com.pl
Facility Name
Medycyna Milorzab sp. z o.o.
City
Łódź
State/Province
Lódzkie
ZIP/Postal Code
93-118
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marcin Wojtera
Phone
+48422072718
Email
marcin.s.wojtera@gmail.com
Facility Name
Krakowska Akademia Neurologii Sp. z o.o.
City
Kraków
State/Province
Malopolskie
ZIP/Postal Code
31-505
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Andrzej Szczudlik
Phone
+48124269280
Email
andrzej.szczudlik@neurologia.org.pl
Facility Name
FutureMeds Warszawa Centrum
City
Warszawa
State/Province
Mazowieckie
ZIP/Postal Code
00-215
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Krystyna Gospodarczyk-Szot
Phone
+48607656436
Email
krystyna.szot@futuremeds.com
Facility Name
Centrum Medyczne Silmedic Sp z o o
City
Katowice
State/Province
Slaskie
ZIP/Postal Code
40-282
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ilona Palka-Kisielowska
Phone
+48539444411
Email
ikisielowska@silmedic.pl
Facility Name
Novo-Med Zielinski i wsp. Sp.J.
City
Katowice
State/Province
Slaskie
ZIP/Postal Code
40-650
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tomasz Zielinski
Phone
+48322030106
Email
tzielinski@op.pl
Facility Name
Neuro-Medic Janusz Zbrojkiewicz
City
Katowice
State/Province
Slaskie
ZIP/Postal Code
40-686
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Janusz Zbrojkiewicz
Phone
+48322521420
Email
jzbrojkiewicz@op.pl
Facility Name
Kiepury Clinic
City
Sosnowiec
State/Province
Slaskie
ZIP/Postal Code
41-200
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Agnieszka Stepanczak
Phone
+48531947085
Email
agulakula@yahoo.com
Facility Name
Clinical Hospital Center Dragisa Misovic Dedinje
City
Belgrade
ZIP/Postal Code
11000
Country
Serbia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vladimir Diligenski
Phone
+381637708765
Email
vldiligenski@gmail.com
First Name & Middle Initial & Last Name & Degree
Vladimir Diligenski
Facility Name
University Clinical Center of Serbia, Clinic for neurology
City
Belgrade
ZIP/Postal Code
11000
Country
Serbia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Elka Stefanova
Phone
+381637041074
Email
steela21@gmail.com
First Name & Middle Initial & Last Name & Degree
Elka Stefanova
Facility Name
Special Hospital for Psychiatric Diseases
City
Kovin
ZIP/Postal Code
26220
Country
Serbia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jovanka Petrovic
Phone
+38163529054
Email
petrovicjoka@yahoo.com
First Name & Middle Initial & Last Name & Degree
Jovanka Petrovic
Facility Name
University Clinical Center Nis, Clinic for neurology
City
Niš
ZIP/Postal Code
18000
Country
Serbia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vuk Milosevic
Phone
+3818888888888
Email
vuk.milosevic@gmail.com
First Name & Middle Initial & Last Name & Degree
Vuk Milosevic
Facility Name
Clinical Centre of Vojvodina, Clinic of Neurology
City
Novi Sad
ZIP/Postal Code
21000
Country
Serbia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marija Semnic
Phone
+381213830223
Email
memoryns@gmail.com
First Name & Middle Initial & Last Name & Degree
Marija Semnic
Facility Name
Special Hospital for Psychiatric Diseases ''Dr Slavoljub Bakalovic''
City
Vršac
ZIP/Postal Code
26300
Country
Serbia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dusica Kirilov
Phone
+381628805101
Email
dusicakirilov@gmail.com
First Name & Middle Initial & Last Name & Degree
Dusica Kirilov

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

We'll reach out to this number within 24 hrs